TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Astellas Pharma AB
Closing information (x1000 NOK)
Closing information | 2024/03 | 2023/03 | 2022/03 |
Turnover |
38,583
|
44,003
|
38,289 |
Financial expenses |
70
|
159
|
674 |
Earnings before taxes |
877
|
2,006
|
1,366 |
EBITDA |
597
|
2,165
|
1,404 |
Total assets |
72,265
|
56,356
|
42,078 |
Current assets |
72,265
|
56,356
|
42,078 |
Current liabilities |
31,459
|
18,358
|
10,108 |
Equity capital |
40,806
|
37,998
|
31,969 |
- share capital |
258
|
249
|
211 |
Employees (average) |
16
![]() |
16
|
18 |
Financial ratios
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Solvency |
56.5%
|
67.4%
|
76.0% |
Turnover per employee |
2,411
|
2,750
|
2,127 |
Profit as a percentage of turnover |
2.3%
|
4.6%
|
3.6% |
Return on assets (ROA) |
1.3%
|
3.8%
|
4.8% |
Current ratio |
229.7%
|
307.0%
|
416.3% |
Return on equity (ROE) |
2.1%
|
5.3%
|
4.3% |
Change turnover |
-5,880
|
2,662
|
-6,398 |
Change turnover % |
-13%
|
6%
|
-14% |
Chg. No. of employees |
0
|
-2
|
-1 |
Chg. No. of employees % |
0%
|
-11%
|
-5% |
Total value of public sale
Fiscal year | 2024/03 | 2023/03 | 2022/03 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.